CRTBX Performance — Potomac Tactical Rotation Fund, Institutional Class Shares
Data updated: 2026-09-14
CRTBX returned +10.68% year to date and +20.53% over one year to Jun 2026. Annualised returns are +9.61% over 3 years and +5.86% over 5 years. Against its US Large Blend category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $132, against $157 for the category, and to $121 over one year, against $118. Volatility over the past three years was 8.34% a year. In the 12 months to Jun 2026 the fund took in a net $81.8M, and assets reached $280.01M.
CRTBX Growth of $100
What $100 invested in Potomac Tactical Rotation Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | CRTBX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $121 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $132 | $157 |
| 5 years (Jul 2021 – Jun 2026) | $133 | $161 |
| Since data start (Jul 2020 – Jun 2026) | $170 | $217 |
CRTBX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +10.68% |
| 1 year | +20.53% |
| 3 years (annualised) | +9.61% |
| 5 years (annualised) | +5.86% |
CRTBX Annual Returns
Calendar-year total returns of Potomac Tactical Rotation Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +10.68% |
| 2025 | +9.93% |
| 2024 | +10.18% |
| 2023 | +0.53% |
| 2022 | −0.45% |
| 2021 | +9.01% |
| 2020 (Jul–Dec) | +16.22% |
CRTBX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.0% | +2.1% | −2.5% | +2.8% | +2.8% | +2.1% | — | — | — | — | — | — |
| 2025 | +2.0% | −2.0% | −3.3% | +2.1% | −0.2% | +2.5% | +2.4% | +1.9% | +0.6% | +0.6% | +3.1% | 0.0% |
| 2024 | +0.4% | +2.1% | +0.6% | −0.7% | +2.3% | +1.1% | +0.8% | −2.5% | +2.0% | −1.2% | +7.0% | −1.8% |
| 2023 | +1.6% | −4.1% | +3.2% | +1.2% | −3.3% | +4.1% | +1.7% | −2.6% | −4.4% | −2.9% | +3.0% | +3.8% |
| 2022 | −4.9% | −2.4% | −0.1% | +3.7% | −0.7% | −1.3% | +1.5% | −1.0% | −0.3% | +5.7% | −0.5% | +0.4% |
| 2021 | +1.2% | +3.3% | +2.4% | +2.1% | +1.2% | −0.6% | +1.2% | +1.3% | −6.3% | +4.8% | −2.2% | +0.7% |
| 2020 | — | — | — | — | — | — | +2.8% | +0.3% | +0.5% | −3.7% | +9.9% | +5.9% |
CRTBX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 8.34%
- 3-year Sharpe ratio: 0.61 (vs 4.5% risk-free rate)
- Best month: +6.95% (Nov 2024)
- Worst month: −4.40% (Sep 2023)
CRTBX Fund Flows
Monthly money in and out of Potomac Tactical Rotation Fund, from SEC Form N-PORT.
- 12-month net flow: $81.8M
- 12-month gross sales (incl. reinvestments): $163.1M
- Sales ÷ redemptions: 2.01×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $17.7M | $4.0M | $13.7M |
| May 2026 | $15.0M | $3.8M | $11.1M |
| Apr 2026 | $13.8M | $33.8M | −$20.1M |
| Mar 2026 | $13.3M | $7.6M | $5.7M |
| Feb 2026 | $11.6M | $3.8M | $7.8M |
| Jan 2026 | $11.4M | $4.0M | $7.4M |
| Dec 2025 | $26.7M | $6.3M | $20.4M |
| Nov 2025 | $10.4M | $5.4M | $5.0M |
| Oct 2025 | $17.1M | $3.3M | $13.8M |
| Sep 2025 | $8.8M | $2.3M | $6.5M |
| Aug 2025 | $8.0M | $2.2M | $5.7M |
| Jul 2025 | $9.3M | $4.7M | $4.6M |
CRTBX Assets Under Management
Net assets of Potomac Tactical Rotation Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $280.01M |
| 2026-03-31 | $255.29M |
| 2025-12-31 | $228.73M |
| 2025-09-30 | $201.06M |
| 2025-06-30 | $175.10M |
| 2025-03-31 | $152.07M |
| 2024-12-31 | $150.64M |
| 2024-09-30 | $148.93M |
| 2024-06-30 | $149.53M |
| 2024-03-31 | $141.72M |
| 2023-12-31 | $119.43M |
| 2023-09-30 | $100.72M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.